VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $268,204 | -88.4% | 34,607 | -82.8% | 0.00% | -100.0% |
| Q2 2023 | $2,302,274 | +260.3% | 201,072 | +235.4% | 0.00% | – |
| Q3 2020 | $639,000 | -15.5% | 59,944 | +0.1% | 0.00% | – |
| Q2 2020 | $756,000 | -1.8% | 59,891 | -28.8% | 0.00% | – |
| Q1 2020 | $770,000 | -30.6% | 84,107 | +5.7% | 0.00% | – |
| Q4 2019 | $1,110,000 | -83.6% | 79,604 | -79.8% | 0.00% | -100.0% |
| Q3 2019 | $6,773,000 | -40.9% | 393,555 | -6.6% | 0.00% | -33.3% |
| Q2 2019 | $11,464,000 | +957.6% | 421,155 | +643.6% | 0.00% | – |
| Q1 2019 | $1,084,000 | +19.0% | 56,639 | -41.6% | 0.00% | – |
| Q4 2018 | $911,000 | +251.7% | 96,909 | +630.3% | 0.00% | – |
| Q2 2018 | $259,000 | -73.4% | 13,269 | -77.4% | 0.00% | – |
| Q4 2017 | $974,000 | – | 58,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |